Chromosome 6q deletion correlates with poor prognosis and low
relative expression of FOXO3 in chronic lymphocytic leukemia
patients

J 2017

Chromosome 6q deletion correlates with poor prognosis and low relative expression of FOXO3 in chronic lymphocytic leukemia patients

JAROŠOVÁ, Marie, M. HRUBA, Alexandra OLTOVÁ, Karla PLEVOVÁ, L. KRUZOVA et. al.

Basic information

Original name

Chromosome 6q deletion correlates with poor prognosis and low relative expression of FOXO3 in chronic lymphocytic leukemia patients

Authors

JAROŠOVÁ, Marie (203 Czech Republic, guarantor, belonging to the institution), M. HRUBA (203 Czech Republic), Alexandra OLTOVÁ (203 Czech Republic, belonging to the institution), Karla PLEVOVÁ (203 Czech Republic, belonging to the institution), L. KRUZOVA (203 Czech Republic), E. KRIEGOVA (203 Czech Republic), R. FILLEROVA (203 Czech Republic), Eva KORIŤÁKOVÁ (203 Czech Republic, belonging to the institution), Michael DOUBEK (203 Czech Republic, belonging to the institution), D. LYSAK (203 Czech Republic), V. PROCHAZKA (203 Czech Republic), Marek MRÁZ (203 Czech Republic, belonging to the institution), K. INDRAK (203 Czech Republic) and T. PAPAJIK (203 Czech Republic)

Edition

American Journal of Hematology, NJ 07030-577 United States, John Wiley & Sons, 2017, 0361-8609

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30205 Hematology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 5.303

RIV identification code

RIV/00216224:14110/17:00095685

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1002/ajh.24852

UT WoS

000409203200010

Keywords in English

Chromosome 6q

Abstract

V originále

Detection of genetic changes has improved the current risk stratification in chronic lymphocytic leukemia (CLL).1,2 Among the known recurrent chromosomal abnormalities,1 6q deletion is less frequent and controversy surrounding its prognostic significance still remains.

Links

NV15-31834A, research and development project

Name: Vliv selekce genomických poškození na průběh chronické lymfocytární leukémie

NV16-29622A, research and development project

Name: VLIV TERAPEUTICKÉ INHIBICE BCR SIGNALIZACE NA GENOVOU EXPRESI U B BUNĚČNÝCH MALIGNIT A JEJÍ PROGNOSTICKÝ A PREDIKTIVNÍ VÝZNAM

Citovat

JAROŠOVÁ, Marie, M. HRUBA, Alexandra OLTOVÁ, Karla PLEVOVÁ, L. KRUZOVA, E. KRIEGOVA, R. FILLEROVA, Eva KORIŤÁKOVÁ, Michael DOUBEK, D. LYSAK, V. PROCHAZKA, Marek MRÁZ, K. INDRAK and T. PAPAJIK. Chromosome 6q deletion correlates with poor prognosis and low relative expression of FOXO3 in chronic lymphocytic leukemia patients. American Journal of Hematology. NJ 07030-577 United States: John Wiley & Sons, 2017, vol. 92, No 10, p. "E604"-"E607", 5 pp. ISSN 0361-8609. Available from: https://dx.doi.org/10.1002/ajh.24852.

@article{1400041,
   author = {Jarošová, Marie and Hruba, M. and Oltová, Alexandra and Plevová, Karla and Kruzova, L. and Kriegova, E. and Fillerova, R. and Koriťáková, Eva and Doubek, Michael and Lysak, D. and Prochazka, V. and Mráz, Marek and Indrak, K. and Papajik, T.},
   article_location = {NJ 07030-577 United States},
   article_number = {10},
   doi = {http://dx.doi.org/10.1002/ajh.24852},
   keywords = {Chromosome 6q},
   language = {eng},
   issn = {0361-8609},
   journal = {American Journal of Hematology},
   title = {Chromosome 6q deletion correlates with poor prognosis and low relative expression of FOXO3 in chronic lymphocytic leukemia patients},
   volume = {92},
   year = {2017}
}

TY  - JOUR
ID  - 1400041
AU  - Jarošová, Marie - Hruba, M. - Oltová, Alexandra - Plevová, Karla - Kruzova, L. - Kriegova, E. - Fillerova, R. - Koriťáková, Eva - Doubek, Michael - Lysak, D. - Prochazka, V. - Mráz, Marek - Indrak, K. - Papajik, T.
PY  - 2017
TI  - Chromosome 6q deletion correlates with poor prognosis and low relative expression of FOXO3 in chronic lymphocytic leukemia patients
JF  - American Journal of Hematology
VL  - 92
IS  - 10
SP  - "E604"-"E607"
EP  - "E604"-"E607"
PB  - John Wiley & Sons
SN  - 03618609
KW  - Chromosome 6q
N2  - Detection of genetic changes has improved the current risk stratification in chronic lymphocytic leukemia (CLL).1,2 Among the known recurrent chromosomal abnormalities,1 6q deletion is less frequent and controversy surrounding its prognostic significance still remains.
ER  -

JAROŠOVÁ, Marie, M. HRUBA, Alexandra OLTOVÁ, Karla PLEVOVÁ, L. KRUZOVA, E. KRIEGOVA, R. FILLEROVA, Eva KORIŤÁKOVÁ, Michael DOUBEK, D. LYSAK, V. PROCHAZKA, Marek MRÁZ, K. INDRAK and T. PAPAJIK. Chromosome 6q deletion correlates with poor prognosis and low relative expression of FOXO3 in chronic lymphocytic leukemia patients. \textit{American Journal of Hematology}. NJ 07030-577 United States: John Wiley \&{} Sons, 2017, vol.~92, No~10, p.~''E604''-''E607'', 5 pp. ISSN~0361-8609. Available from: https://dx.doi.org/10.1002/ajh.24852.

Detailed Information on Publication Record